Goldman Sachs Downgrades Harmony Biosciences Holdings Inc. (HRMY) to Sell, 'Risks to out-year revenue emerging'
Tweet Send to a Friend
(Updated - September 25, 2023 4:59 AM EDT)
Goldman Sachs analyst Corinne Jenkins downgraded Harmony Biosciences Holdings Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Corinne Jenkins downgraded Harmony Biosciences Holdings Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
